EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Additional Metadata
Keywords	Biological antirheumatic drugs, Disease-modifying antirheumatic drugs, EULAR recommendations, Managements of rheumatoid arthritis, Synthetic antirheumatic drugs
Persistent URL	doi.org/10.1136/annrheumdis-2013-204573, hdl.handle.net/1765/68716
Journal	Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases
Organisation	Rheumatology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Smolen, J.S, Landewé, R.B.M, Breedveld, F.C, Buch, T, Burmester, G.R, Dougados, M, … van der Heijde, D. (2014). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases, 73(3), 492–509. doi:10.1136/annrheumdis-2013-204573

Publication